HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noboru Konishi Selected Research

RK 682

5/2020Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noboru Konishi Research Topics

Disease

51Neoplasms (Cancer)
05/2020 - 04/2002
40Prostatic Neoplasms (Prostate Cancer)
06/2019 - 01/2002
16Carcinoma (Carcinomatosis)
05/2020 - 04/2002
11Urinary Bladder Neoplasms (Bladder Cancer)
05/2020 - 04/2009
7Carcinogenesis
12/2013 - 04/2002
6Spinal Cord Ischemia
12/2012 - 04/2003
4Lower Urinary Tract Symptoms
01/2019 - 12/2014
4Neoplasm Metastasis (Metastasis)
08/2017 - 03/2006
4Hepatocellular Carcinoma (Hepatoma)
11/2016 - 01/2003
4Adenocarcinoma
12/2013 - 07/2002
4Ischemia
02/2012 - 03/2007
4Hypotension (Low Blood Pressure)
02/2012 - 03/2005
3Margins of Excision
06/2019 - 08/2005
3Inflammation (Inflammations)
01/2017 - 01/2007
3Carcinoma in Situ
10/2016 - 04/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2015 - 04/2004
2Non-Muscle Invasive Bladder Neoplasms
10/2017 - 10/2016
2Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2016 - 08/2016
2Hypoxia (Hypoxemia)
04/2015 - 02/2012
2Lupus Nephritis
09/2014 - 10/2013
2Brain Ischemia (Cerebral Ischemia)
11/2011 - 04/2010
2Ataxia (Dyssynergia)
10/2009 - 02/2007
2Glioblastoma (Glioblastoma Multiforme)
07/2009 - 02/2005
2Lymphatic Metastasis
01/2007 - 07/2005
2Squamous Cell Carcinoma of Head and Neck
07/2005 - 07/2003
2Neuralgia (Stump Neuralgia)
06/2004 - 02/2004
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2004 - 07/2003
1Overactive Urinary Bladder (Overactive Bladder)
08/2017
1Fibrosis (Cirrhosis)
01/2017

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
05/2017 - 01/2003
12Small Interfering RNA (siRNA)IBA
05/2020 - 01/2008
7Syndecan-1 (Syndecan 1)IBA
05/2020 - 07/2009
7Messenger RNA (mRNA)IBA
03/2012 - 02/2003
6Prostate-Specific Antigen (Semenogelase)IBA
06/2019 - 07/2003
6AndrogensIBA
01/2015 - 11/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2012 - 04/2002
6Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2008 - 04/2002
5Cadherins (E-Cadherin)IBA
05/2020 - 04/2002
5Biological ProductsIBA
10/2016 - 08/2005
5DNA (Deoxyribonucleic Acid)IBA
10/2016 - 07/2002
5Neuroprotective AgentsIBA
12/2012 - 08/2009
5Phosphotransferases (Kinase)IBA
10/2009 - 06/2003
5Cyclin-Dependent Kinase Inhibitor p16IBA
01/2008 - 04/2002
4Iodine-125IBA
01/2019 - 01/2009
4salicylhydroxamic acid (SHAM)IBA
02/2012 - 04/2003
4IsofluraneFDA LinkGeneric
02/2012 - 03/2005
4Serine (L-Serine)FDA Link
01/2009 - 01/2002
3Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
05/2020 - 07/2009
3Estrogens (Estrogen)FDA Link
05/2017 - 06/2003
3matrigelIBA
05/2017 - 09/2007
3RNA (Ribonucleic Acid)IBA
10/2016 - 02/2012
3MicroRNAs (MicroRNA)IBA
08/2016 - 10/2015
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 04/2009
3AntibodiesIBA
09/2014 - 07/2003
3Hormones (Hormone)IBA
07/2009 - 01/2006
2Interleukin-6 (Interleukin 6)IBA
01/2018 - 10/2017
2CytokinesIBA
01/2018 - 01/2011
2CollagenIBA
11/2017 - 05/2017
2Biomarkers (Surrogate Marker)IBA
11/2017 - 08/2005
2Keratin-19 (Keratin 19)IBA
11/2017 - 11/2016
2Keratins (Keratin)IBA
11/2016 - 04/2009
2VimentinIBA
01/2016 - 04/2009
2atelocollagenIBA
04/2015 - 07/2009
2E-SelectinIBA
09/2014 - 10/2013
2Protein Isoforms (Isoforms)IBA
03/2013 - 01/2010
2Minocycline (Cyclops)FDA LinkGeneric
12/2012 - 11/2011
2NADPH Oxidases (NAD(P)H oxidase)IBA
10/2012 - 10/2011
2CalciumIBA
03/2012 - 05/2006
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2011 - 02/2004
24- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA
01/2008 - 07/2004
2AntigensIBA
01/2008 - 10/2006
2Opioid Analgesics (Opioids)IBA
01/2008 - 07/2004
2Mitogen-Activated Protein KinasesIBA
09/2007 - 11/2002
2beta CateninIBA
07/2006 - 11/2005
2Complementary DNA (cDNA)IBA
07/2005 - 01/2004
22-MethoxyestradiolIBA
01/2004 - 06/2003
2Death Domain ReceptorsIBA
01/2004 - 06/2003
2Etoposide (VP 16)FDA LinkGeneric
06/2003 - 10/2002
2FenretinideIBA
03/2003 - 11/2002
1RK 682IBA
05/2020
1NitrosaminesIBA
05/2020
1heparanaseIBA
05/2020
1EnzymesIBA
05/2020
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2018
1Interleukin-8 (Interleukin 8)IBA
01/2018
1nuclear matrix protein 22IBA
11/2017
1Collagen Type XIIIIBA
05/2017
1Growth Hormone (Somatotropin)IBA
05/2017
1Collagen Type IV (Type IV Collagen)IBA
05/2017
1Nonmuscle Myosin Type IIBIBA
01/2017

Therapy/Procedure

15Therapeutics
09/2017 - 08/2005
12Prostatectomy (Retropubic Prostatectomy)
06/2019 - 11/2002
11Brachytherapy
01/2019 - 01/2009
5Radiotherapy
06/2019 - 10/2014
4Drug Therapy (Chemotherapy)
06/2014 - 01/2006
3Anesthesia
02/2012 - 03/2007
2Cystectomy
01/2017 - 01/2016
2Intraperitoneal Injections
02/2012 - 03/2007
2Catheters
11/2011 - 04/2003
2Lasers (Laser)
01/2004 - 07/2003